How M.D. was paid
$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| David Angulo, M.D.President and Chief Executive Officer | $626,041 | $283,961 | $307,309 | $312,370 | $10,500 | $1,540,181 |
| Ivor MacleodChief Financial Officer | $467,480 | $99,912 | $108,127 | $173,143 | $10,500 | $859,162 |
| Scott SukenickChief Legal Officer | $459,958 | $99,912 | $108,127 | $172,209 | $10,500 | $833,015 |
What changed and why
- $1.5MDavid Angulo received total compensation of $1,540,181 for 2025, representing a decrease from the prior year.
- 90%The annual performance bonus for the CEO was achieved at 90% of target.
- $653KThe Board of Directors increased Dr. Angulo's annual salary to $653,000 in January 2026.
- Long-term incentives included annual restricted stock units and stock option grants.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.